Avon Technologies PLC · LSE:AVON
Avon Technologies — FY2026 Earnings Presentation
36 slides from Avon Technologies's earnings presentation, November 2026

Slide 1: A stronger business. A clear path forward. 2026 Full Year Results
A stronger business. A clear path forward. 2026 Full Year Results

Slide 2: STAR has delivered a stronger core business
STAR has delivered a stronger core business Moving from transformation Final year of A platform for to: transformation growth complete Improve Grow Compound We have a clear plan to build from it 2

Slide 3: 2026: a year of effective execution
2026: a year of effective execution

Slide 4: Strong growth, profit expansion and cash generation
Strong growth, profit expansion and cash generation +1 3% +51% Order intake Revenue Adjusted operating profit $353.6m $353.7m $60.7m (FY25: $351.5m) (FY25: $313.9m ) (FY25: $40.3m) +57% +900 Adjusted Return on bps Cash conversion basic EPS Invested Capital 143.3c 27.6% 93% (FY25: 91.2c) (FY25: 18.6%

Slide 5: FY26 highlights
FY26 highlights FY26 FY25 CC* $m $m ▲ ▲ Strong order intake driven by DoW** Orders received 353.6 351.5 0.6% 0.2% helmet orders in H2 and continued strong Closing order book 262.7 262.8 (0.0%) 0.2% respiratory and filter demand Revenue 353.7 313.9 12.7% 12.1% Revenue up 12.1%, record filter volumes

Slide 6: Avon Protection: double-digit growth against a strong prior year comparator
Avon Protection: double -digit growth against a strong prior year comparator Order book remains strong versus history: Strong underlying performance despite FY26 FY25 DoW M50 & M53A1 contract expired in $m $m ▲ 2025 & FY25 benefiting from Ukraine- Orders received 184.1 213.8 (13.9)% related demand.

Slide 7: Team Wendy: Transformation delivered
Team Wendy: Transformation delivered Strengthened order book giving DoW revenue visibility into FY28. Acceleration of Commercial Americas orders in H2. FY26 FY25 Expect order book to fall as we deliver $m $m ▲ on DoW orders this year. Orders received 169.5 137.7 23.1% Closing order book 151.9 145.8

Slide 8: Group operating profit bridge
Group operating profit bridge Gross margin 17.2% $3.0m $60.7m $7.8m $0.7m $1.9m $0.9m $12.7m ($3.1m) 12.8% ($3.5m) $40.3m FY25 TW ACH dilution AP growth Tariff refunds Investment IT savings One-off Other FY26 improvement in sales operating recurring tax benefits savings Revenue and gross margin incr

Slide 9: Balance sheet
Balance sheet FY26 FY25 Continue to fall reflecting prudent $m $m capitalisation policy Intangible assets 108.7 115.4 Property, plant and equipment 46.0 42.3 Net other non-current assets 20.3 31.0 Inventories 65.7 55.5 Increased production levels, Other current assets 60.5 52.3 partially offset by m

Slide 10: Cash flow
Cash flow FY26 FY25 $m $m Adjusted EBITDA 70.9 51.5 Share-based payments and defined benefit pension scheme costs 7.9 6.7 Higher inventory levels Working capital (13.1) (11.7) Cash flows from operations before exceptional items 65.7 46.5 Transformational costs paid (6.8) (13.1) Cash flows from opera

Slide 11: IT transformation project delivering rapid payback and lasting operational benefits
IT transformation project delivering rapid payback and lasting operational benefits Key changes: Simpler, lower -cost IT aligned to A stronger platform technology business priorities for improvement • Fewer, more capable systems • More on-site, business -aligned support • Streamlined processes and b

Slide 12: Strong cash generation and balance sheet capacity
Strong cash generation and balance sheet capacity… Free cash flow will improve dramatically ...combining with a strong balance sheet to over the next three years... give us increased optionality: …create options for further growth 12

Slide 13: FY27 guidance
FY27 guidance Revenue growth Adjusted operating Free cash flow profit margin Mid-single -digit Within 16 -18% C.$50 -60m growth range Growth across both Team Wendy operational Transformation businesses, with Team Wendy improvements continue, programmes complete, helmet deliveries offsetting partly o

Slide 14: STAR built a stronger platform for growth
STAR built a stronger platform for growth

Slide 15: STAR built a resilient and cash-generative business
STAR built a resilient and cash -generative business Strengthen System embedded Transformation projects Lots of opportunity complete to improve further New step-change programmes and Increasing investment in opportunities R&D, sales, marketing, people and new product M&A if it meets our development

Slide 16: Strengthen: CI is embedded and high impact
Strengthen: CI is embedded and high impact Group Direct Labour Productivity 1 Group Scrap (% of revenue) 2 Group Inventory Turns 3 $700k 5.0% 3.50 $600k 4.5% 3.00 4.0% $500k 3.5% -54% 2.50 $400k 3.0% (vs. H123) 2.00 $300k +54% 2.5% 1.50 +14% (vs. H123) 2.0% (vs. H123) $200k 1.5% 1.00 $100k 1.0% 0.50

Slide 17: Cleveland transformed into a scalable, high-volume manufacturing operation
Cleveland transformed into a scalable, high -volume manufacturing operation Annual helmet From batch production capacity production to has increased >300k repeatable, high - c.12x volume flow ...with potential to manufacturing grow further 230k Able to meet major US DoW programmes & support future g

Slide 18: HPW transformed while growing, creating capacity for the future
HPW transformed while growing, creating capacity for the future Flow manufacturing Redesigned production around integrated cells, Productivity +78% reducing WIP, movement and lead times. Execution without disruption Revenue per sq m +121% Batch Relocated 38 moulding presses while continuing to serve

Slide 19: Advance: core respiratory leadership continues to drive growth and recurring demand
Advance: core respiratory leadership continues to drive growth and recurring demand Programme expansions & installed base growth: CBRN Ensemble First full CBRN ensemble order $145m total NSPA from Europe . Filters & orders sustainment 16 NATO nations. $27m of filter orders Expanding installed base f

Slide 20: Revolutionise: targeted investment has created new growth platforms
Revolutionise : targeted investment has created new growth platforms US suits US rebreather NATO Combination Next gen US respiratory Systems >$800m >$40m c.0.5m 1.8m market opportunity accessible market FM50 NATO users M50 respirators in US military service • Down -selected to phase 3 and • Builds o

Slide 21: Advance: extending core programmes across US DoW and international markets
Advance: extending core programmes across US DoW and international markets Core programmes & recurring demand: Next Generation ACH Gen II IHPS Pads & liner N. America Meeting contractual $40m order secured. production rates. systems commercial Two awards totalling $40m. Recurring demand from US Sign

Slide 22: Revolutionise: building a broader revenue base
Revolutionise : building a broader revenue base 0.6% 5 states 4.5% Make up >50% of Military ballistic Current market share current US sales helmet CAGR International expansion N.America commercial & federal Future DoW programmes • Expand the addressable market • Extend military head protection • Sha

Slide 23: Improve | Grow | Compound
a Improve | Grow |..Ci i: AVON TECHNOLOGIES PLC

Slide 24: Demonstrated improvement creates a strong organic platform and capacity to grow
Demonstrated improvement creates a strong organic platform and capacity to grow Compound Grow Compound value Improve over the long term Maximise the core and accelerate • Acquire selectively in Codified how we growth protection technology improve businesses • Strengthen our market - • Improve and gr

Slide 25: Compound: building a protection technology compounder
Compound: building a protection technology compounder Improve what we buy Compound Acquire selectively and demonstrate we shareholder value in protection can apply our system through our buy and technology markets to an acquisition improve model We will accelerate where we see value and as capabilit

Slide 26: Value creation through strong businesses
Value creation through strong businesses How we expect the current Strong cash generation Group five year targets: portfolio to perform organically: over the next three years, supporting firepower to drive faster growth: >5% 16-18% >$175m >5x >$600m >18% >10% Further Revenue Operating Cumulative Gro

Slide 27: Risk and opportunity update
Risk and opportunity update Risks: Opportunities: • Sustaining Team Wendy production • New programmes and international performance while maintaining quality, growth: step-change programmes not fully delivery and manufacturing discipline reflected in forecasts • US political backdrop impacting short

Slide 28: A stronger, more efficient and increasingly cash-generative business
A stronger, more efficient and increasingly cash -generative business Strong momentum entering FY27: IMPROVE GROW COMPOUND • Market-leading positions Drive performance Maximise the core Allocate capital with • Attractive end markets through continuous and invest behind discipline and pursue • Clear

Slide 29: Appendix
Appendix

Slide 30: Our FY27 Group strategy summary
Our FY27 Group strategy summary: Drive higher productivity, cash generation and returns through continuous improvement • Improve productivity, quality and inventory turns • Build leadership capability and organisational strength • Generate cash to reinvest in growth Strengthen our market -leading po

Slide 31: We are the world leader in mission-critical protection
We are the world leader in mission -critical protection CBRN Non-CBRN Integrated Underwater Ballistic helmets Bump helmets Liner & retention Respiratory Respiratory CBRN Respiratory systems Protection Protection Protective Wear Protection $190.3m 2026 revenue $163.4m 2026 revenue 450+ employees 600+

Slide 32: Investment case
Investment case: A stronger Avon is positioned to compound value over the long term LEADING POSITIONS DURABLE ORGANIC GROWTH HIGH RETURN, DISCIPLINED IN ATTRACTIVE COMPETITIVE ABOVE END CASH - REINVESTMENT MARKETS ADVANTAGES MARKETS GENERATIVE CORE • Mission-critical • Long qualifications • Core gro

Slide 33: Technical guidance
Technical guidance FY25 FY26 FY27 guidance $m $m $m Research and development expenditure 13.5 13.8 15-18 Of which cost of customer funded projects 1.5 2.2 2-3 Group expenditure 12.0 11.6 13-16 Capitalised development costs 1.5 2.9 3-4 Expensed research & development costs (excluding amortisation) 10

Slide 34: Glossary
Glossary LATAM Latin America 50 Series Range of masks based on the technology of the M50 mask system LE Law Enforcement ACH Gen II Second-generation Advanced Combat Helmet LTP Lightweight Tactical Polymer APAC Asia-Pacific LTM Last Twelve Months APR Air purifying respirator MENA Middle East and Nort

Slide 35: Avon Protection Portfolio
Avon Protection Portfolio AIR PURIFYING RESPIRATORS (APR) DoW mask FM50 – NATO C50 M53A1 FM53 FM54 HMK150 PC50 FM12 FM51 M69 MITR The military’s choice The first choice for First responder One mask, all The multiple Single mask, The Integrated Riot Entry level, non- Tried and tested Combat vehicle T

Slide 36: Team Wendy Portfolio
Team Wendy Portfolio BALLISTIC BUMP LINERS & RETENTION NEXT GEN INTEGRATED ZAP SOF H-BACK HEAD PROTECTION ADVANCED EPIC AIR® LINER SYSTEM CAM FIT RIFLETECH RECON LINER SYSTEM RETENTION SYSTEM COMBAT HELMET EXFIL® LTP EXFIL® CARBON RETENTION SYSTEM SYSTEM TACTICAL CLOUDLINE® VELCRO® BRAND STANDARD EP
Source: company website
More decks from Avon Technologies PLC
Investor Day (October 2026)82 slides · Oct 7, 2026
Q2 2026 Earnings Presentation53 slides · May 13, 2026
Shareholder Meeting (January 2026)16 slides · Jan 30, 2026
Investor Presentation (2026)12 slides · 2026
FY2025 Earnings Presentation46 slides · Nov 12, 2025
H1 2025 Earnings Presentation56 slides · May 21, 2025